A new report has shown that deaths from HIV, tuberculosis, and malaria could double if systems for health are overwhelmed, treatment and prevention programmes are disrupted and resources are diverted.

Studies in mild-to-moderate cases as well as severe disease leave us still searching for a magic pill. (Editorial)

The objective of the study wast to assess the effectiveness of hydroxychloroquine in patients admitted to hospital with coronavirus disease 2019 (covid-19) pneumonia who require oxygen.

The objective of the study was to assess the efficacy and safety of hydroxychloroquine plus standard of care compared with standard of care alone in adults with coronavirus disease 2019 (covid-19).

Today, the African Union Commission joins the world to celebrate the World Malaria Day by declaring the theme of the day: “Zero Malaria Starts with Me” and committing to step up the fight to end this deadly disease. The theme is inspired by a continental campaign called Zero Malaria Starts With Me led by the Commission in partnership with the RBM Partnership to End Malaria to strengthen the fight against malaria through increased and sustained investment and political will in Africa. The Campaign is active in 14 AU Member States.

Fast forward to 2020 and the malaria landscape has changed considerably. On a global scale, progress has levelled off; according to our latest World malaria report, no gains were achieved in reducing malaria case incidence over the last five years. Worryingly, malaria is on the rise in many countries with a high burden of the disease.

The health of school-aged children (SAC) is often compromised by malaria parasitaemia (MP), soil-transmitted helminths (STH), and malnutrition in the tropics. The aim of this study was to determine the prevalence and influence of MP, STH and malnutrition on haemoglobin (Hb) levels as well as identify its predictors.

The World malaria report 2019 provides a comprehensive update on global and regional malaria data and trends. The report tracks investments in malaria programmes and research as well as progress across all intervention areas: prevention, diagnosis, treatment, elimination and surveillance.

Sub-Saharan African leaders in the highest burden countries are moving quickly to adopt the “High burden to high impact” (HBHI) approach to jumpstart progress against malaria.

Understanding genomic variation and population structure of Plasmodium falciparum across Africa is necessary to sustain progress toward malaria elimination. Genome clustering of 2263 P.

Pages